Back to Search
Start Over
Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1.
- Source :
- Oncologist; Jan2023, Vol. 28 Issue 1, pe77-e81, 5p, 1 Chart, 1 Graph
- Publication Year :
- 2023
-
Abstract
- The monarchE Cohort 1 patient population was enrolled based on high-risk clinicopathological features that can easily be identified as part of routine clinical breast cancer evaluation. Efficacy data from Cohort 1 demonstrate substantial evidence of benefit for adjuvant abemaciclib+ET in patients with HR+, HER2− early breast cancer at high risk of recurrence (ClinicalTrials.gov: NCT03155997 [monarchE]). [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 10837159
- Volume :
- 28
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Oncologist
- Publication Type :
- Academic Journal
- Accession number :
- 161968452
- Full Text :
- https://doi.org/10.1093/oncolo/oyac234